Late-Stage Clinical Data and Future Directions for PD-1/IL-2 Immunotherapy

Thu, Mar 18 | 10:40 AM - 11:00 AM

General Session

Speaker:

PK Morrow, MD Head, Oncology Therapuetic Area Unit Takeda

Industry Specific Content:

Science & Clinical Development

Track:

General Session